Montag & Caldwell’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Hold |
3,221
| – | – | 0.13% | 68 |
|
|
2025
Q1 | $675K | Hold |
3,221
| – | – | 0.16% | 60 |
|
|
2024
Q4 | $572K | Sell |
3,221
-414
| -11% | -$73.6K | 0.12% | 65 |
|
|
2024
Q3 | $718K | Hold |
3,635
| – | – | 0.15% | 59 |
|
|
2024
Q2 | $623K | Sell |
3,635
-87
| -2% | -$14.9K | 0.13% | 63 |
|
|
2024
Q1 | $678K | Sell |
3,722
-63
| -2% | -$11.5K | 0.12% | 58 |
|
|
2023
Q4 | $587K | Hold |
3,785
| – | – | 0.1% | 57 |
|
|
2023
Q3 | $564K | Hold |
3,785
| – | – | 0.07% | 62 |
|
|
2023
Q2 | $510K | Sell |
3,785
-5
| -0.1% | -$674 | 0.06% | 62 |
|
|
2023
Q1 | $604K | Sell |
3,790
-91
| -2% | -$14.5K | 0.08% | 54 |
|
|
2022
Q4 | $627K | Buy |
3,881
+255
| +7% | +$41.2K | 0.09% | 53 |
|
|
2022
Q3 | $486K | Buy |
3,626
+405
| +13% | +$54.3K | 0.07% | 61 |
|
|
2022
Q2 | $493K | Buy |
+3,221
| New | +$493K | 0.07% | 64 |
|
|
2016
Q4 | – | Sell |
-15,100
| Closed | -$952K | – | 87 |
|
|
2016
Q3 | $952K | Sell |
15,100
-9,379
| -38% | -$591K | 0.02% | 47 |
|
|
2016
Q2 | $1.52M | Sell |
24,479
-1,950
| -7% | -$121K | 0.03% | 39 |
|
|
2016
Q1 | $1.51M | Sell |
26,429
-17,876
| -40% | -$1.02M | 0.03% | 39 |
|
|
2015
Q4 | $2.63M | Sell |
44,305
-11,625
| -21% | -$689K | 0.05% | 37 |
|
|
2015
Q3 | $3.04M | Sell |
55,930
-11,970
| -18% | -$651K | 0.05% | 38 |
|
|
2015
Q2 | $4.56M | Sell |
67,900
-3,800
| -5% | -$255K | 0.06% | 39 |
|
|
2015
Q1 | $4.2M | Buy |
71,700
+26,100
| +57% | +$1.53M | 0.05% | 40 |
|
|
2014
Q4 | $2.98M | Buy |
+45,600
| New | +$2.98M | 0.03% | 39 |
|
|
2013
Q4 | – | Sell |
-258,180
| Closed | -$11.5M | – | 97 |
|
|
2013
Q3 | $11.5M | Sell |
258,180
-70,600
| -21% | -$3.16M | 0.09% | 40 |
|
|
2013
Q2 | $13.6M | Buy |
+328,780
| New | +$13.6M | 0.1% | 38 |
|